CS
FLGT icon

Credit Suisse’s Fulgent Genetics FLGT Stock Holding History

Credit Suisse’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$677K Buy
31,209
+865
+3% +$21.5K ﹤0.01% 2490
2023
Q4 		$877K Buy
30,344
+6,121
+25% +$164K ﹤0.01% 2415
2023
Q3 		$648K Sell
24,223
-1,479
-6% -$50.5K ﹤0.01% 2543
2023
Q2 		$952K Sell
25,702
-1,792
-7% -$62.5K ﹤0.01% 2411
2023
Q1 		$858K Sell
27,494
-2,930
-10% -$94.3K ﹤0.01% 2428
2022
Q4 		$906K Buy
30,424
+8,610
+39% +$308K ﹤0.01% 2407
2022
Q3 		$832K Buy
21,814
+6,631
+44% +$332K ﹤0.01% 2451
2022
Q2 		$828K Sell
15,183
-8,073
-35% -$444K ﹤0.01% 2517
2022
Q1 		$1.45M Buy
23,256
+2,840
+14% +$187K ﹤0.01% 2292
2021
Q4 		$2.05M Buy
20,416
+4,981
+32% +$438K ﹤0.01% 2769
2021
Q3 		$1.39M Buy
15,435
+577
+4% +$52.4K ﹤0.01% 3094
2021
Q2 		$1.37M Buy
14,858
+1,795
+14% +$143K ﹤0.01% 3149
2021
Q1 		$1.26M Sell
13,063
-56,169
-81% -$5.8M ﹤0.01% 3162
2020
Q4 		$3.61M Buy
69,232
+35,483
+105% +$1.48M ﹤0.01% 2365
2020
Q3 		$1.35M Buy
+33,749
New +$1.06M ﹤0.01% 2719
2020
Q1 		– Sell
-28,892
Closed -$373K – 4063
2019
Q4 		$373K Buy
+28,892
New +$343K ﹤0.01% 3717

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Credit Suisse's FLGT Position: Q1 2024 in Review

Credit Suisse increased its Fulgent Genetics (FLGT) stake by 2.9% in Q1 2024, buying an estimated $21.5K and bringing the position to 31,209 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Credit Suisse first reported a position in FLGT in Q4 2019 and has held it in 16 quarters since. The position peaked at $3.61M in Q4 2020. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Credit Suisse held 31,209 shares of Fulgent Genetics worth $677K as of Q1 2024.
  • Credit Suisse bought 865 Fulgent Genetics shares in Q1 2024, an estimated $21.5K.
  • Fulgent Genetics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2490 holding.
  • Credit Suisse first reported a position in Fulgent Genetics in Q4 2019 and has held it in 16 quarters since.
  • Credit Suisse's Fulgent Genetics position peaked at $3.61M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.